News

Ohr Pharmaceutical Announces Fiscal Second Quarter 2017 Earnings

NEW YORK, May 11, 2017 (GLOBE NEWSWIRE) — Ohr Pharmaceutical, Inc. (OHRP), a clinical-stage pharmaceutical company developing novel therapies for ophthalmic diseases, today reported results for its second quarter ended March 31, 2017.

2017-06-20T16:15:23+00:00